Survivin Expression in Acute Leukemias and Myelodysplastic Syndromes

References

• Ambrosini, G., Adida, C. and Alfieri, D.C. (1997) "A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma", Nature Medicine, 3, 917–921.
   Google Scholar
• Ambrosini, G., Adida, C., Sirugo, G. and Altieri, D.C. (1998) "Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting", Journal of Biological Chemistry, 273, 11177–11182.
   PubMed Web of Science ®Google Scholar
• Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., et al. (1998) "Control of apoptosis and mitotic spindle checkpoint by surviving", Nature, 396, 580 — 584.
   Google Scholar
• Lu, C.D., Alfieri, D.C. and Tanigawa, N. (1998) "Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas", Cancer Research, 58, 1808–1812.
   PubMed Web of Science ®Google Scholar
• Adida, C., Recher, C., Raffoux, E., Daniel, M.T., Taksin, A.L., Rousselot, P., et al. (2000) "Expression and prognostic significance of survivin in de novo acute myeloid leukemia", British Journal of Hematology, 111, 196–203.
   Google Scholar
• Carter, B.Z., Milella, M., Alfieri, D.C. and Andreeff, M. (2001) . "Cytokine-regulated expression of survivin in myeloid leukemia", Blood, 97, 2784–2790.
   Google Scholar
• Gianani, R., Jarboe, E., Orlicky, D., Frost, M., Bobak, G., Lehner, R., etal. (2001) "Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa", Human Pathology, 32, 119–125.
   PubMed Web of Science ®Google Scholar
• Satoh, K., Kaneko, K., Hirota, M., Masamune, A., Satoh, A. and Shinosegawa, T. (2001) "Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors", Cancer, 92, 271–278.
   Google Scholar
• Adida, C., Berrei, D., Peuchmaur, M., Reyes-Mugica, M. and Altieri, D.C. (1998) "Anti-apoptosis gene, survivin, and prognosis of neuroblastoma", Lancet, 351, 882–883.
   PubMed Web of Science ®Google Scholar
• Adida, C., Haioun, C., Gaulard, P., Lepade, E., Morel, P., Briere, J., et al. (2000) "Prognostic significance of survivin expression in diffuse large B-cell lymphomas", Blood, 96, 1921–1925.
   Google Scholar
• Kawasaki, H., Alfieri, D.C., Lu, CD., Toyoda, M., Tenjo, T. and Tanigawa, N. (1998) "Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer", Cancer Research, 58, 5071 — 5074.
   Google Scholar
• Tanaka, K., Iwamoto, S., Gon, G., Nohara, T., Iwamoto, M. and Tanigawa, N. (2000) "Expression of survivin and its relationship to loss of apoptosis in breast carcinomas", Clinical Cancer Research, 6, 127–134.
   Google Scholar
• Negoescu, A., Lorimier, P., Labat-Moleur, F., Drouet, C., Robert, C., Guillermet, C., et al. (1996) "In situ apoptotic cell labeling by the TUNEL method : improvement and evaluation on cell prepara-tions", The Journal of Histochemistry and Cytochemistry, 44, 959 — 968.
   PubMed Web of Science ®Google Scholar
• Rowan, S. and Fisher, D.E. (1997) "Mechanism of apoptotic cell death", Leukemia, 11, 457–465.
   PubMed Web of Science ®Google Scholar
• Devereaux, Q.L., Takahashi, R., Salvesen, G.S. and Reed, J.C. (1997) "X-linked IAP is a direct inhibitor of cell-death proteases", Nature, 388, 300 — 304.
   Google Scholar
• Tamm, I., Wang, Y., Sausville, E., Scudiero, D.A., Vigna, N., Oltersdorf, T., et al. (1998) "IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs", Cancer Research, 58, 5315–5320.
   PubMed Web of Science ®Google Scholar
• Reed, J.C. (1999) "Dysregulation of apoptosis in cancer", Journal of Clinical Oncology, 17, 2941 —2953.
   PubMed Web of Science ®Google Scholar
• Parker, J.E. and Mufti, G.J. (1998) "Ineffective hemopoiesis and apoptosis in myelodysplastic syndromes", British Journal of Hematology, 101, 220–230.
   PubMed Web of Science ®Google Scholar
• Yoshida, Y. and Mufti, G.J. (1999) "Apoptosis and its significance in MDS: controversies revisited", Leukemia Research, 23, 777–785.
   PubMed Web of Science ®Google Scholar
• Parker, J.E., Mufti, G.J., Rasool, F., Mijovic, A., Devereux, S. and Pagliuca, A. (2000) "The role of apoptosis, proliferation, and Bc1-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS", Blood, 96, 3932— 3938.
   PubMedGoogle Scholar
• Rosenfeld, C. and List, A. (2000) "A hypothesis for the pathogen-esis of myelodysplastic syndromes: implications for new therapies", Leukemia, 14, 2–8.
   PubMed Web of Science ®Google Scholar
• Invernizzi, R., Pecci, A., Bellotti, L. and Ascari, E. (2001) "Expression of p53, Bc1-2 and Ras oncoproteins and apoptosis levels in acute leukemias and myelodysplastic syndromes", Leuke-mia and Lymphoma, 42, 481 —489.
   PubMed Web of Science ®Google Scholar
• Pecci, A., Travaglino, E., Klersy, C. and Invernizzi, R. (2003) "Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow", Acta Hematologica, 109, 29–34.
   PubMed Web of Science ®Google Scholar
• Rajapaksa, R., Ginzton, N., Rott, L.S. and Greenberg, P.L. (1996) "Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells", Blood, 88, 4275–4287.
   Google Scholar
• Hellstrom-Lindberg, E., Kanter-Lewensohn, L. and Ost, A. (1997) "Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin", Leukemia Research, 21, 415–425.
   Google Scholar
• Tsoplou, P., Kouraklis-Symeonidis, A., Thanopoulou, E., Zikos, P., Orphanos, V. and Zoumbos, N.C. (1999) "Apoptosis in patients with myelodysplastic syndromes: differential involvement of mar-row cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes", Leukemia, 13, 1554–1563.
   Google Scholar
• Invernizzi, R. (2002) "The role of apoptosis in myelodysplastic syndrome", Hematologica, 87, 337–339.
   Google Scholar
• Li, F., Ackermann, E.J., Bennett, CF., Rothermel, AL., Plescia, J., Tognin, S., et al. (1999) "Pleiotropic cell-division defects and apoptosis induced by interference with survivin function", Nature Cell Biology, 1, 461 — 466.
   Google Scholar
• Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T. and Tokuhisa, T. (1999) "Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation", Proceedings National Academy of Science USA, 96, 1457 — 1462.
   Google Scholar
• Fortugno, P., Wall, N.R., Giodini, A., O'Connor, D.S., Plescia, J., Padgett, KM., et al. (2002) "Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function", Journal of Cell Science, 115, 575 — 585.
   PubMed Web of Science ®Google Scholar
• Fukuda, S. and Pelus, L.M. (2001) "Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34 + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis", Blood, 98, 2091 — 2100.
   Google Scholar
• Velculescu, YE., Madden, S.L., Zhang, L., Lash, A.E., Yu, J., Rago, C., et al. (1999) "Analysis of human transcriptomes", Nature Genetics, 23, 387 — 388.
   PubMed Web of Science ®Google Scholar
• Shinozawa, I., Inokuchi, K., Wakabayashi, I. and Dan, K. (2000) "Disturbed expression of the anti-apoptosis gene, Survivin, and EPR-1 in hematological malignancies", Leukemia Research, 24, 965 —970.
   PubMed Web of Science ®Google Scholar
• Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., et al. (2001) "Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia", Blood, 97, 2777–2783.
   PubMed Web of Science ®Google Scholar
• Moriai, R., Asanuma, K., Kobayashi, D., Yajima, T., Yagihashi, A., Yamada, M. and Watanabe, N. (2001) "Quantitative analysis of the anti-apoptotic gene survivin expression in malignant hemato-poietic cells", Anticancer Research, 21, 595–600.
   Google Scholar
• Mori, A., Wada, H., Nishimura, Y., Okamoto, T., Takemoto, Y. and Kakishita, E. (2002) "Expression of the antiapoptosis gene survivin in human leukemia", International Journal of Hematology, 75, 161 — 165.
   Web of Science ®Google Scholar
• Nakayama, K. and Kamihira, S. (2002) "Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology", Leukemia and Lympho-ma, 43, 2249 — 2255.
   PubMed Web of Science ®Google Scholar
• Altieri, D.C. and Marchisio, C. (1999) "Survivin apoptosis: an interloper between cell death and cell proliferation in cancer", Laboratory Investigation, 79, 1327 — 1333.
   Google Scholar
• Kim, P.J., Plescia, J., Clevers, H., Fearon, E.R. and Altieri, D.C. (2003) "Survivin and molecular pathogenesis of colorectal cancer", Lancet, 362, 205–209.
   Google Scholar
• Grossman, D., Kim, P.J., Schechner, J.S. and Alfieri, D.C. (2001) "Inhibition of melanoma tumor growth in vivo by survivin targeting", Proceedings National Academy of Science USA, 98, 635 —640.
   PubMed Web of Science ®Google Scholar
• Altieri, D.C. (2003) "Validating survivin as a cancer therapeutic target", Nature Reviews Cancer, 3, 46— 54.
   PubMed Web of Science ®Google Scholar
• Blanc-Brude, O.P., Mesri, M., Wall, N.R., Plescia, J., Dohi, T. and Altieri, D.C. (2003) Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clinical Cancer Research, 9, 2683 — 2692.
   PubMed Web of Science ®Google Scholar
• Schmidt, S.M., Schag, K., Mueller, M.R., Week, M.M., Appel, S., Kanz, L., et al. (2003) "Survivin is a shared tumor associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T-cells", Blood, 102, 571 —576.
   Google Scholar
• Campos, L., Sabido, O., Viallet, A., Vasselon, C. and Guyotat, D. (1999) "Expression of apoptosis-controlling proteins in acute leukemia cells", Leukemia and Lymphoma, 33, 499–509.
   PubMed Web of Science ®Google Scholar
• Badran, A., Yoshida, A., Wano, Y., Mutoh, M., Imamura, S., Yamashita, T., et al. (2003) "Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome", International Journal of Oncology, 22, 59–64.
   Google Scholar
• Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., et al. (1995) "Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis", American Journal of Hematology, 48, 143— 154.
   Google Scholar
• Shimazaki, K., Ohshima, K., Suzumiya, J., Kawasaki, C. and Kikuchi, M. (2000) "Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes", British Journal of Hematology, 110, 584— 590.
   Google Scholar
• Albitar, M., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H.M., et al. (2002) "Myelodysplastic syndrome is not merely `preleukemia—, Blood, 100, 791–798.
   Google Scholar
• Huh, Y.O., Mani, I., Estey, E., Giles, F., Kantarjian, H., Freireich, E., et al. (2002) "More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia", Leuke-mia, 16, 2249–2252.
   Google Scholar
• Blanc-Brude, O.P., Yu, J., Simosa, H., Conte, M.S., Sessa, W.C. and Alfieri, D.C. (2002) "Inhibitor of apoptosis protein survivin regulates vascular injury", Nature Medicine, 8, 987 —994.
   Google Scholar